These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26288838)

  • 1. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
    Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
    EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
    Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
    Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB1 gene inactivation by chromothripsis in human retinoblastoma.
    McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
    Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Level
    Roohollahi K; de Jong Y; van Mil SE; Fabius AWM; Moll AC; Dorsman JC
    Ophthalmol Sci; 2022 Sep; 2(3):100188. PubMed ID: 36245757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
    Ryl T; Afanasyeva E; Hartmann T; Schwermer M; Schneider M; Schröder C; Wagemanns M; Bister A; Kanber D; Steenpass L; Schramm K; Jones B; Jones DTW; Biewald E; Astrahantseff K; Hanenberg H; Rahmann S; Lohmann DR; Schramm A; Ketteler P
    Commun Biol; 2024 Jul; 7(1):919. PubMed ID: 39079981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
    Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
    Li WL; Buckley J; Sanchez-Lara PA; Maglinte DT; Viduetsky L; Tatarinova TV; Aparicio JG; Kim JW; Au M; Ostrow D; Lee TC; O'Gorman M; Judkins A; Cobrinik D; Triche TJ
    J Mol Diagn; 2016 Jul; 18(4):480-93. PubMed ID: 27155049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
    Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
    Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic differences between retinoma and retinoblastoma.
    Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
    Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling identifies different sub-types of retinoblastoma.
    Kapatai G; Brundler MA; Jenkinson H; Kearns P; Parulekar M; Peet AC; McConville CM
    Br J Cancer; 2013 Jul; 109(2):512-25. PubMed ID: 23756868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
    Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
    Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
    Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
    Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
    Schmidt MJ; Prabakar RK; Pike S; Yellapantula V; Peng CC; Kuhn P; Hicks J; Xu L; Berry JL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution SNP array profiling identifies variability in retinoblastoma genome stability.
    Mol BM; Massink MP; van der Hout AH; Dommering CJ; Zaman JM; Bosscha MI; Kors WA; Meijers-Heijboer HE; Kaspers GJ; Riele Ht; Moll AC; Cloos J; Dorsman JC
    Genes Chromosomes Cancer; 2014 Jan; 53(1):1-14. PubMed ID: 24249257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.